SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

AstraZeneca Says FDA Grants Priority Review to Sone-Ve BLA

AstraZeneca said its biologics license application for Sone-Ve was granted priority review in the US.

Related stories